315 related articles for article (PubMed ID: 30206043)
1. Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System.
Wainer Z; Wright GM; Gough K; Daniels MG; Russell PA; Choong P; Conron M; Ball D; Solomon B
Clin Lung Cancer; 2018 Nov; 19(6):e933-e944. PubMed ID: 30206043
[TBL] [Abstract][Full Text] [Related]
2. Impact of sex on prognostic host factors in surgical patients with lung cancer.
Wainer Z; Wright GM; Gough K; Daniels MG; Choong P; Conron M; Russell PA; Alam NZ; Ball D; Solomon B
ANZ J Surg; 2017 Dec; 87(12):1015-1020. PubMed ID: 27625078
[TBL] [Abstract][Full Text] [Related]
3. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.
Chansky K; Sculier JP; Crowley JJ; Giroux D; Van Meerbeeck J; Goldstraw P;
J Thorac Oncol; 2009 Jul; 4(7):792-801. PubMed ID: 19458556
[TBL] [Abstract][Full Text] [Related]
4. Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancer.
Wainer Z; Daniels MG; Callahan J; Binns D; Hicks RJ; Antippa P; Russell PA; Alam NZ; Conron M; Solomon B; Wright GM
J Nucl Med; 2012 Nov; 53(11):1676-85. PubMed ID: 22984219
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.
Noma D; Inamura K; Matsuura Y; Hirata Y; Nakajima T; Yamazaki H; Hirai Y; Ichinose J; Nakao M; Ninomiya H; Mun M; Nakagawa K; Masuda M; Ishikawa Y; Okumura S
Clin Lung Cancer; 2018 Jan; 19(1):e109-e122. PubMed ID: 29066222
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 7th and 8th editions of the UICC/AJCC TNM staging for non-small cell lung cancer in a non-metastatic North American cohort undergoing primary radiation treatment.
Koul R; Rathod S; Dubey A; Bashir B; Chowdhury A
Lung Cancer; 2018 Sep; 123():116-120. PubMed ID: 30089581
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Conventional TNM and Novel TNMB Staging Systems for Non-Small Cell Lung Cancer.
Haro GJ; Sheu B; Cook NR; Woodard GA; Mann MJ; Kratz JR
JAMA Netw Open; 2019 Dec; 2(12):e1917062. PubMed ID: 31808928
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of the 8th edition AJCC TNM staging system for non-small-cell lung cancer is not applicable to lung cancer as a second primary malignancy.
Shi S; Xie H; Yin W; Zhang Y; Peng X; Yu F; Shemanski KA; Kim AW; Wang X
J Surg Oncol; 2020 Jun; 121(8):1233-1240. PubMed ID: 32170977
[TBL] [Abstract][Full Text] [Related]
9. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
[TBL] [Abstract][Full Text] [Related]
10. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
[No Abstract] [Full Text] [Related]
11. Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non-small-cell Lung Cancer.
Chen K; Chen H; Yang F; Sui X; Li X; Wang J
Clin Lung Cancer; 2017 Nov; 18(6):e457-e466. PubMed ID: 28539214
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
13. External Validation of the New International Association for the Study of Lung Cancer Tumor, Node, and Metastasis 8th Edition Staging System and Updated T Descriptors in Determining Prognosis for Patients With Non-Small Cell Lung Cancer Patients With N3 Disease.
Shin JY; Yoon JK; Marwaha G
Clin Lung Cancer; 2017 Nov; 18(6):e481-e489. PubMed ID: 28559200
[TBL] [Abstract][Full Text] [Related]
14. Result of the 6-min walk test is an independent prognostic factor of surgically treated non-small-cell lung cancer.
Marjanski T; Badocha M; Wnuk D; Dziedzic R; Ostrowski M; Sawicka W; Rzyman W
Interact Cardiovasc Thorac Surg; 2019 Mar; 28(3):368-374. PubMed ID: 30203070
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
[TBL] [Abstract][Full Text] [Related]
16. A Population-Based Study of Outcomes in Surgically Resected T3N0 Non-Small Cell Lung Cancer in The Netherlands, Defined Using TNM-7 and TNM-8; Justification of Changes and an Argument to Incorporate Histology in the Staging Algorithm.
Blaauwgeers H; Damhuis R; Lissenberg-Witte BI; de Langen AJ; Senan S; Thunnissen E
J Thorac Oncol; 2019 Mar; 14(3):459-467. PubMed ID: 30408568
[TBL] [Abstract][Full Text] [Related]
17. The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer.
Travis WD; Giroux DJ; Chansky K; Crowley J; Asamura H; Brambilla E; Jett J; Kennedy C; Rami-Porta R; Rusch VW; Goldstraw P;
J Thorac Oncol; 2008 Nov; 3(11):1213-23. PubMed ID: 18978555
[TBL] [Abstract][Full Text] [Related]
18. Poor prognostic factors in patients with stage IB non-small cell lung cancer according to the seventh edition TNM classification.
Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
Chest; 2011 Apr; 139(4):855-861. PubMed ID: 20724736
[TBL] [Abstract][Full Text] [Related]
19. Marital status independently predicts non-small cell lung cancer survival: a propensity-adjusted SEER database analysis.
Chen Z; Yin K; Zheng D; Gu J; Luo J; Wang S; Chen H
J Cancer Res Clin Oncol; 2020 Jan; 146(1):67-74. PubMed ID: 31786738
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of adjuvant therapy in T4 non-small cell lung cancer: An inverse probability of treatment weighting analysis.
Song YT; Yang SL; Fu Z; Liu XH; Yan SY; Wang ZH; Qin TT; Jiang HW; Jin Y; Yin P
Thorac Cancer; 2019 Mar; 10(3):472-482. PubMed ID: 30628189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
